![](/img/cover-not-exists.png)
A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort
Werner, Theresa L., Wade, Mark L., Agarwal, Neeraj, Boucher, Kenneth, Patel, Jesal, Luebke, Aaron, Sharma, SunilVolume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0288-5
Date:
December, 2015
File:
PDF, 438 KB
english, 2015